These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. The induction of immunogenic cell death by photodynamic therapy in B16F10 cells in vitro is effected by the concentration of the photosensitizer. Morais JAV; Almeida LR; Rodrigues MC; Azevedo RB; Muehlmann LA Photodiagnosis Photodyn Ther; 2021 Sep; 35():102392. PubMed ID: 34133961 [TBL] [Abstract][Full Text] [Related]
49. Photodynamic therapy of hepatocellular carcinoma using tetra-triethyleneoxysulfonyl zinc phthalocyanine as photosensitizer. Ogbodu RO; Nitzsche B; Ma A; Atilla D; Gürek AG; Höpfner M J Photochem Photobiol B; 2020 Jul; 208():111915. PubMed ID: 32480203 [TBL] [Abstract][Full Text] [Related]
50. C6-pyridinium ceramide sensitizes SCC17B human head and neck squamous cell carcinoma cells to photodynamic therapy. Boppana NB; Stochaj U; Kodiha M; Bielawska A; Bielawski J; Pierce JS; Korbelik M; Separovic D J Photochem Photobiol B; 2015 Feb; 143():163-8. PubMed ID: 25635908 [TBL] [Abstract][Full Text] [Related]
51. Association between the photodynamic loss of Bcl-2 and the sensitivity to apoptosis caused by phthalocyanine photodynamic therapy. Usuda J; Azizuddin K; Chiu SM; Oleinick NL Photochem Photobiol; 2003 Jul; 78(1):1-8. PubMed ID: 12929741 [TBL] [Abstract][Full Text] [Related]
52. Photodynamic effects of new silicon phthalocyanines: in vitro studies utilizing rat hepatic microsomes and human erythrocyte ghosts as model membrane sources. Zaidi SI; Agarwal R; Eichler G; Rihter BD; Kenney ME; Mukhtar H Photochem Photobiol; 1993 Aug; 58(2):204-10. PubMed ID: 8415911 [TBL] [Abstract][Full Text] [Related]
54. Acid-triggered controlled release and fluorescence-switchable phthalocyanine nanoassemblies combined with O Liu X; Chen L; Chen Z Bioorg Chem; 2024 Feb; 143():106986. PubMed ID: 37995641 [TBL] [Abstract][Full Text] [Related]
55. A tumor-targeted Ganetespib-zinc phthalocyanine conjugate for synergistic chemo-photodynamic therapy. Huang L; Wei G; Sun X; Jiang Y; Huang Z; Huang Y; Shen Y; Xu X; Liao Y; Zhao C Eur J Med Chem; 2018 May; 151():294-303. PubMed ID: 29627724 [TBL] [Abstract][Full Text] [Related]
56. PEGylated Dendrimers as Drug Delivery Vehicles for the Photosensitizer Silicon Phthalocyanine Pc 4 for Candidal Infections. Hutnick MA; Ahsanuddin S; Guan L; Lam M; Baron ED; Pokorski JK Biomacromolecules; 2017 Feb; 18(2):379-385. PubMed ID: 28117573 [TBL] [Abstract][Full Text] [Related]
57. Gold standard assessment of immunogenic cell death induced by photodynamic therapy: From in vitro to tumor mouse models and anti-cancer vaccination strategies. Mishchenko TA; Balalaeva IV; Turubanova VD; Saviuk MO; Shilyagina NY; Krysko O; Vedunova MV; Krysko DV Methods Cell Biol; 2024; 183():203-264. PubMed ID: 38548413 [TBL] [Abstract][Full Text] [Related]
58. Tumor-selective new piperazine-fragmented silicon phthalocyanines initiate cell death in breast cancer cell lines. Sarı C; Nalçaoğlu A; Değirmencioğlu İ; Celep Eyüpoğlu F J Photochem Photobiol B; 2021 Mar; 216():112143. PubMed ID: 33550219 [TBL] [Abstract][Full Text] [Related]
59. A Nanostructured Phthalocyanine/Albumin Supramolecular Assembly for Fluorescence Turn-On Imaging and Photodynamic Immunotherapy. Wang R; Kim KH; Yoo J; Li X; Kwon N; Jeon YH; Shin SK; Han SS; Lee DS; Yoon J ACS Nano; 2022 Feb; 16(2):3045-3058. PubMed ID: 35089696 [TBL] [Abstract][Full Text] [Related]